Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $45.9250 (5.38%) ($45.9250 - $45.9250) on Wed. Apr. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 75 | Latest Price | $45.9250(5.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.7% a day on average for past five trading days. | Weekly Trend | HALO advances 2.8% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWO(49%) IWM(47%) IWC(43%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.43% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) GLD(-1%) TLT(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $43.5(5.57%) | 10 Day Moving Average | $42.98(6.85%) | 20 Day Moving Average | $42.71(7.53%) | To recent high | -11.6% | To recent low | 16% | Market Cap | $6.277b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |